Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (295) 295
Patent (11) 11
Publication (5) 5
Book Chapter (2) 2
Book / eBook (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (113) 113
humans (112) 112
life sciences & biomedicine (112) 112
middle aged (81) 81
male (79) 79
adult (78) 78
female (74) 74
hematology (72) 72
aged (58) 58
oncology (35) 35
treatment outcome (34) 34
biological and medical sciences (29) 29
medical sciences (29) 29
adolescent (28) 28
aged, 80 and over (25) 25
young adult (22) 22
analysis (21) 21
cancer (20) 20
hematologic and hematopoietic diseases (20) 20
transplantation (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
care and treatment (18) 18
chronic myeloid leukemia (18) 18
chemotherapy (17) 17
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (17) 17
antineoplastic agents - therapeutic use (15) 15
disease-free survival (15) 15
hematopoietic stem cell transplantation (15) 15
leukemia (15) 15
recurrence (15) 15
risk factors (15) 15
stem cells (15) 15
abridged index medicus (14) 14
multiple myeloma (14) 14
follow-up studies (13) 13
hematopoietic stem cells (13) 13
leukemia, lymphocytic, chronic, b-cell - drug therapy (13) 13
medicin och hälsovetenskap (13) 13
survival analysis (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
child (12) 12
immunology (12) 12
remission induction (12) 12
research (12) 12
tumors (12) 12
actuating-floats (11) 11
antineoplastic agents (11) 11
blasting (11) 11
cocks (11) 11
devices for venting or aerating (11) 11
engineering elements and units (11) 11
general measures for producing and maintaining effectivefunctioning of machines or installations (11) 11
heating (11) 11
lighting (11) 11
mechanical engineering (11) 11
taps (11) 11
thermal insulation in general (11) 11
valves (11) 11
weapons (11) 11
general & internal medicine (10) 10
genetic aspects (10) 10
hematology, oncology and palliative medicine (10) 10
medical colleges (10) 10
medicine, general & internal (10) 10
patients (10) 10
prognosis (10) 10
drug resistance, neoplasm (9) 9
hemic and lymphatic diseases (9) 9
nilotinib (9) 9
prospective studies (9) 9
pyrimidines - therapeutic use (9) 9
retrospective studies (9) 9
survival rate (9) 9
toxicity (9) 9
treatment (9) 9
bone marrow (8) 8
cladribine - administration & dosage (8) 8
dose-response relationship, drug (8) 8
drug administration schedule (8) 8
medicine (8) 8
medicine & public health (8) 8
antimitotic agents (7) 7
chronic lymphocytic leukemia (7) 7
cladribine (7) 7
clinical trials (7) 7
health aspects (7) 7
hypereosinophilic syndrome (7) 7
medical and health sciences (7) 7
mutation (7) 7
pharmacology. drug treatments (7) 7
relapse (7) 7
survival (7) 7
time factors (7) 7
transplantation, homologous (7) 7
antibodies, monoclonal - adverse effects (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
cancer research (6) 6
cardiovascular system & cardiology (6) 6
clinical medicine (6) 6
dasatinib (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients
by Nowak, Jacek and Kościńska, Katarzyna and Mika‐Witkowska, Renata and Rogatko‐Koroś, Marta and Mizia, Sylwia and Jaskuła, Emilia and Polak, Małgorzata and Mordak‐Domagała, Monika and Lange, Janusz and Gronkowska, Anna and Jędrzejczak, Wiesław Wiktor and Kyrcz‐Krzemień, Sławomira and Markiewicz, Mirosław and Dzierżak‐Mietła, Monika and Tomaszewska, Agnieszka and Nasiłowska‐Adamska, Barbara and Szczepiński, Andrzej and Hałaburda, Kazimierz and Hellmann, Andrzej and Komarnicki, Mieczysław and Gil, Lidia and Czyż, Anna and Wachowiak, Jacek and Barańska, Małgorzata and Kowalczyk, Jerzy and Drabko, Katarzyna and Goździk, Jolanta and Wysoczańska, Barbara and Bogunia‐Kubik, Katarzyna and Graczyk‐Pol, Elżbieta and Witkowska, Agnieszka and Marosz‐Rudnicka, Anna and Nestorowicz, Klaudia and Dziopa, Joanna and Szlendak, Urszula and Warzocha, Krzysztof and Lange, and Andrzej and Polish Donor-Recipient Matching and Polish Donor-Recipient Matching Study Group
American journal of hematology, ISSN 0361-8609, 10/2014, Volume 89, Issue 10, pp. E176 - E183
Life Sciences & Biomedicine | Hematology | Science & Technology | Acute Disease | Killer Cells, Natural | Humans | Histocompatibility Antigens Class I - immunology | Child, Preschool | Donor Selection - methods | Hematopoietic Stem Cell Transplantation | Genotype | Infant | Male | Graft vs Host Disease - immunology | Neoplasms - therapy | Allografts | Neoplasms - immunology | Adolescent | Adult | Female | Graft vs Host Disease - prevention & control | Unrelated Donors | Neoplasms - pathology | Child | Receptors, KIR - immunology | Killer cells | Transplantation | Analysis | Hematopoietic stem cells | Stem cells | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
by Burger, Jan A and Tedeschi, Alessandra and Barr, Paul M and Robak, Tadeusz and Owen, Carolyn and Ghia, Paolo and Bairey, Osnat and Hillmen, Peter and Bartlett, Nancy L and Li, Jianyong and Simpson, David and Grosicki, Sebastian and Devereux, Stephen and McCarthy, Helen and Coutre, Steven and Quach, Hang and Gaidano, Gianluca and Maslyak, Zvenyslava and Stevens, Don A and Janssens, Ann and Offner, Fritz and Mayer, Jiří and O’Dwyer, Michael and Hellmann, Andrzej and Schuh, Anna and Siddiqi, Tanya and Polliack, Aaron and Tam, Constantine S and Suri, Deepali and Cheng, Mei and Clow, Fong and Styles, Lori and James, Danelle F and Kipps, Thomas J and RESONATE-2 Investigators
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrazoles - therapeutic use | Chlorambucil - adverse effects | Chlorambucil - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Diarrhea - chemically induced | Disease-Free Survival | Antineoplastic Agents - adverse effects | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Female | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neutropenia - chemically induced | Pyrazoles - adverse effects | Clinical trials | Treatment outcome | Usage | Lymphocytic leukemia | Drug therapy | Analysis | Chronic lymphatic leukemia | Leukemia | Diarrhea | Fatigue | Nausea | Lymphatic leukemia | Lymphoma | Hemorrhage | Survival | Cough | Chlorambucil | Immunosuppression | Chemotherapy | Vomiting | Immunotherapy | Hemoglobin | Myelosuppression | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text First‐line R‐CVP versus R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4
by Walewski, Jan and Paszkiewicz‐Kozik, Ewa and Michalski, Wojciech and Rymkiewicz, Grzegorz and Szpila, Tomasz and Butrym, Aleksandra and Giza, Agnieszka and Zaucha, Jan M and Kalinka‐Warzocha, Ewa and Wieczorkiewicz, Agata and Zimowska‐Curyło, Dagmara and Knopińska‐Posłuszny, Wanda and Tyczyńska, Agata and Romejko‐Jarosińska, Joanna and Dąbrowska‐Iwanicka, Anna and Gruszecka, Beata and Jamrozek‐Jedlińska, Maria and Borawska, Anna and Hołda, Waldemar and Porowska, Agnieszka and Romanowicz, Agnieszka and Hellmann, Andrzej and Stella‐Hołowiecka, Beata and Deptała, Andrzej and Jurczak, Wojciech
British journal of haematology, ISSN 0007-1048, 03/2020, Volume 188, Issue 6, pp. 898 - 906
indolent lymphoma | rituximab maintenance | first‐line induction immunochemotherapy | Life Sciences & Biomedicine | Hematology | Science & Technology | Toxicity | Mucosa | Rituximab | Prednisone | Lymphoid tissue | Lymphoma | Doxorubicin | Survival | Vincristine | Cyclophosphamide | Mucosal-associated lymphoid tissue | Remission | Neutropenia | Index Medicus | Research Paper | Haematological Malignancy – Clinical
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Real-time microcirculation imaging during beating-heart coronary artery bypass grafting
by Los, Andrzej and Hellmann, Marcin
Kardiologia polska (1957), ISSN 0022-9032, 08/2020, Volume 78, Issue 7-8, pp. 780 - 781
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology
Journal Article
Details down arrow
5. Full Text Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
by Valent, Peter, MD and Klion, Amy D., MD and Horny, Hans-Peter, MD and Roufosse, Florence, MD, PhD and Gotlib, Jason, MD and Weller, Peter F., MD and Hellmann, Andrzej, MD and Metzgeroth, Georgia, MD and Leiferman, Kristin M., MD and Arock, Michel, PharmD, PhD and Butterfield, Joseph H., MD and Sperr, Wolfgang R., MD and Sotlar, Karl, MD and Vandenberghe, Peter, MD, PhD and Haferlach, Torsten, MD and Simon, Hans-Uwe, MD, PhD and Reiter, Andreas, MD and Gleich, Gerald J., MD
Journal of allergy and clinical immunology, ISSN 0091-6749, 2012, Volume 130, Issue 3, pp. 607 - 612.e9
Allergy and Immunology | eosinophilic leukemia | hypereosinophilia of undetermined significance | classification | criteria | Hypereosinophilic syndrome | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Fundamental immunology | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Terminology as Topic | Eosinophils - physiology | Hypereosinophilic Syndrome - classification | Eosinophilia - classification | Humans | Eosinophilia - diagnosis | Medical colleges | Platelet-derived growth factor | Parasitic diseases | Analysis | Leukemia | Fibroblast growth factors | Allergic reaction | Public health | Lymphatic system | Disease | Cytokines | Genes | Stem cells | Classification | Thrombosis | Chromosomes | Tumors | Defects | Index Medicus | Abridged Index Medicus | Clinical trials | Conferences | Eosinophilia | Hypersensitivity | Leukocytes (eosinophilic) | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. The current status and the future of internal medicine: a voice in the discussion
by Hellmann, Andrzej
Polskie archiwum medycyny wewne̦trznej, ISSN 0032-3772, 01/2016, Volume 126, Issue 12, pp. 1054 - 1057
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Specialization | Internal Medicine - trends | Humans | Internal Medicine - manpower
Journal Article
Details down arrow
7. Full Text Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)
by Tadeusz Robak and Krzysztof Jamroziak and Joanna Gora-Tybor and Beata Stella-Holowiecka and Lech Konopka and Bernadetta Ceglarek and Krzysztof Warzocha and Ilona Seferynska and Jarosław Piszcz and Malgorzata Calbecka and Aleksandra Kostyra and Jadwiga Dwilewicz-Trojaczek and Anna Dmoszyñska and Krystyna Zawilska and Andrzej Hellmann and Andrzej Zdunczyk and Stanislaw Potoczek and Magdalena Piotrowska and Krzysztof Lewandowski and Jerzy Z. Blonski
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1863 - 1869
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Immunophenotyping | Male | Survival Rate | Treatment Outcome | Vidarabine - analogs & derivatives | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Remission Induction | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Cladribine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Vidarabine - administration & dosage | Cytogenetic Analysis | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
by Cortes, Jorge E and Heidel, Florian H and Hellmann, Andrzej and Fiedler, Walter and Smith, B. Douglas and Robak, Tadeusz and Montesinos, Pau and Pollyea, Daniel A and DesJardins, Pierre and Ottmann, Oliver and Ma, Weidong Wendy and Shaik, M. Naveed and Laird, A. Douglas and Zeremski, Mirjana and O’Connell, Ashleigh and Chan, Geoffrey and Heuser, Michael
Leukemia, ISSN 0887-6924, 02/2019, Volume 33, Issue 2, pp. 379 - 389
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Survival Rate | Cytarabine - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Benzimidazoles - administration & dosage | Phenylurea Compounds - administration & dosage | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Female | Aged | Drug Therapy, Combination | Myelodysplastic Syndromes - drug therapy | Medical colleges | Chemotherapy | Comparative analysis | Cancer | Slopes | Pneumonia | Myeloid leukemia | Leukemia | Fatigue | Patients | Survival | Myelodysplastic syndrome | Confidence intervals | Randomization | Cytarabine | Risk assessment | Remission | Acute myeloid leukemia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Acquired von Willebrand syndrome during systemic mastocytosis: An analysis of 21 cases
by Mital, Andrzej and Prejzner, Witold and Hellmann, Andrzej
Polskie archiwum medycyny wewne̦trznej, ISSN 0032-3772, 2018, Volume 128, Issue 7-8, pp. 491 - 493
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | von Willebrand Diseases - epidemiology | Adult | Female | Male | Aged | Mastocytosis, Systemic - complications | von Willebrand Diseases - etiology
Journal Article
Details down arrow
10. Full Text Role of Donor Activating KIR–HLA Ligand–Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients
by Nowak, Jacek and Kościńska, Katarzyna and Mika-Witkowska, Renata and Rogatko-Koroś, Marta and Mizia, Sylwia and Jaskuła, Emilia and Polak, Małgorzata and Mordak-Domagała, Monika and Lange, Janusz and Gronkowska, Anna and Jędrzejczak, Wiesław Wiktor and Kyrcz-Krzemień, Sławomira and Markiewicz, Mirosław and Dzierżak-Mietła, Monika and Tomaszewska, Agnieszka and Nasiłowska-Adamska, Barbara and Szczepiński, Andrzej and Hałaburda, Kazimierz and Hellmann, Andrzej and Czyż, Anna and Gil, Lidia and Komarnicki, Mieczysław and Wachowiak, Jacek and Barańska, Małgorzata and Kowalczyk, Jerzy and Drabko, Katarzyna and Goździk, Jolanta and Wysoczańska, Barbara and Bogunia-Kubik, Katarzyna and Graczyk-Pol, Elżbieta and Witkowska, Agnieszka and Marosz-Rudnicka, Anna and Nestorowicz, Klaudia and Dziopa, Joanna and Szlendak, Urszula and Warzocha, Krzysztof and Lange, Andrzej and Polish Donor-Recipient Matching Study Group and Polish Donor-Recipient Matching St
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 5, pp. 829 - 839
Hematology, Oncology and Palliative Medicine | Missing ligand | Activating killer cell immunoglobulin-like receptors | Bone marrow donor selection | Hematopoietic stem cell transplantation | Malignant diseases | Natural killer cell education | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic Neoplasms - therapy | Receptors, KIR - genetics | Histocompatibility Testing | Humans | Middle Aged | Histocompatibility Antigens Class I - immunology | Child, Preschool | Hematopoietic Stem Cell Transplantation | Graft vs Tumor Effect - immunology | Infant | Male | Histocompatibility Antigens Class I - genetics | Killer Cells, Natural - pathology | Allografts | Adolescent | Killer Cells, Natural - immunology | Adult | Female | Unrelated Donors | Hematologic Neoplasms - genetics | Hematologic Neoplasms - immunology | Graft vs Tumor Effect - genetics | Child | Receptors, KIR - immunology | Killer cells | Hematopoietic stem cells | Stem cells | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi‐agent chemotherapy
by Walewski, Jan and Hellmann, Andrzej and Siritanaratkul, Noppadol and Ozsan, Guner Hayri and Ozcan, Muhit and Chuncharunee, Suporn and Goh, Ai Sim and Jurczak, Wojciech and Koren, Jan and Paszkiewicz‐Kozik, Ewa and Wang, Bingxia and Singh, Shalini and Huebner, Dirk and Engert, Andreas and Tresckow, Bastian
British journal of haematology, ISSN 0007-1048, 11/2018, Volume 183, Issue 3, pp. 400 - 410
novel anti‐tumour agents | relapsed/refractory | phase IV | Hodgkin lymphoma | brentuximab vedotin | novel anti-tumour agents | Life Sciences & Biomedicine | Hematology | Science & Technology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Antineoplastic Combined Chemotherapy Protocols | Male | Survival Rate | Immunoconjugates - administration & dosage | Stem Cell Transplantation | Disease-Free Survival | Adolescent | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Aged | Immunoconjugates - adverse effects | Chemotherapy | Transplantation | Lymphomas | Stem cells | Cancer | Transplants & implants | Toxicity | Diarrhea | Radiation therapy | Peripheral neuropathy | Lymphoma | Patients | Survival | Fever | Confidence intervals | Salvage | CD30 antigen | Medical prognosis | Safety | Hodgkin's disease | Neutropenia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights